2PLunkettW, Gandhi V. EvoLution of the arabinosides and the pharmacoLogy of fLudarabine[J]. Drug, 1994, 47(6):30.
3Gandhi V, Estey E, Keating M J, et al. FLudarabine potentiates metaboLism of cytarabine in patients with acute myeLogenous Leukemia during therapy[J]. J CLin OncoL, 1993, 11 (1): 116.
6Hane L M, Friedrichsen K, HaneL A., et al. Mito -fLag as saLvage therapy for repLapsed and refractory acutemyeLoid Leukemia[J]. OnkoLo-gie, 2001, 24: 356.
7Weiss L, AbduL2Hai A, Or R, et al. FLudarabine in combination with cycLophosphamide decreases ineidence of GVHD and maintains effec-tive graft-versus-Leukemia effect after aLLogeneie stem ceLL transp Lantation in murine Lymphocytic Leukemia[J]. Bone Marrow Transp Lant, 2003, 31: 11.
7Park LS,Waldron PE,Friend D,et al.Interleukior3,GM-CS-FandG-CSF receptor expression on cell lines and primary leukemia cells:receptor heterogeneity and relationship to growth factor responsiveness[J].Blood,1989,74:56-65
8Wormannn B,Reuter C,Zuhisdrof M,et al.Experimental basis for the use of recombinant human granitlncyte-maerophage colonysitionrlating factor in patients with acute myeloid leukemia[J].Sc min Oncol,1994,21:39-43
9Stone RM.The difficult problem of acute myeloid leukemia in the older adult[J].CA Cancer J Clin,2002,52:363-367
